Flamel Takes Lupin To Court Over Generic Coreg
A generic version of the drug would infringe on U.S. Patent No. 6,022,562, which is held by Flamel and associated with Coreg, according to a press release from Flamel.
The '562 patent, called "Medicinal and/or nutritional microcapsules for oral administration," covers a process for the production of microcapsules and a description of the...
To view the full article, register now.